As a proof of concept, we first investigated whether IL-1α could impart protection to neurons undergoing the in vitro stroke analogue oxygen glucose deprivation (OGD) or using an in vitro model of post-stroke toxicity, exposure to NMDA. The gene discussed is IL1A; the disease is Stroke.